DTaP-IPV vaccine is a combination vaccine whose full generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine (IPV).

[1] It protects against the infectious diseases diphtheria, tetanus, pertussis, and poliomyelitis.

[1] Branded formulations marketed in the USA are Kinrix from GlaxoSmithKline[3] and Quadracel from Sanofi Pasteur.

[5][6] In Japan, the formulation is called 四種混合(shishukongou - "mixture of 4").

Astellas markets it under the クアトロバック ('Quattro-back') formulation, while another is available from Mitsubishi Tanabe Pharma named テトラビック ('Tetrabic').